Pipeline

ProgramDiseasesDiscoveryPreclinicalPhase 1Phase 1b/2Phase 2/3
ATYR1923 Pulmonary Sarcoidosis
Chronic Hypersensitivity Pneumonitis (CHP)
Connective Tissue Disease ILD (CTD-ILD)
tRNA Synthetase Candidates Undisclosed
NRP2 Candidates Undisclosed
Program Target Phase
ATYR1923 Pulmonary Sarcoidosis Phase 1b/2
Chronic Hypersensitivity Pneumonitis (CHP) Phase 1
Connective Tissue Disease ILD (CTD-ILD) Phase 1
tRNA Synthetase Candidates Undisclosed Discovery
NRP2 Candidates Undisclosed Discovery